Press

Universal DX Initiates Clinical Trial for FDA Approval of Signal-C® Colorectal Cancer Screening Blood Test

Universal DX Initiates Clinical Trial for FDA Approval of Signal-C® Colorectal Cancer Screening Blood Test

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

Universal DX Presents Data from Large, 1,000-patient, Multi-Cohort Study Proving 93% Sensitivity for Colorectal Cancer and 54% Sensitivity for Advanced Adenoma at 92% Specificity

Universal DX Presents Data from Large, 1,000-patient, Multi-Cohort Study Proving 93% Sensitivity for Colorectal Cancer and 54% Sensitivity for Advanced Adenoma at 92% Specificity

New Data from Universal DX: Combining Copy Number Variation (CNV) with cfDNA Fragment Size Information Could Serve as Promising New Avenue for Early Detection of Colorectal Cancer (CRC)

New Data from Universal DX: Combining Copy Number Variation (CNV) with cfDNA Fragment Size Information Could Serve as Promising New Avenue for Early Detection of Colorectal Cancer (CRC)

New Data from Universal DX Demonstrates Effective Detection of Early-stage Colorectal Cancer Using Combination of Methylation, Fragmentation and Machine Learning

New Data from Universal DX Demonstrates Effective Detection of Early-stage Colorectal Cancer Using Combination of Methylation, Fragmentation and Machine Learning

Universal DX Presents Methylation Biomarker Data at AACR Special Conference: Precision Prevention, Early Detection, and Interception of Cancer

Universal DX Presents Methylation Biomarker Data at AACR Special Conference: Precision Prevention, Early Detection, and Interception of Cancer

New Findings from Universal DX: Through a Simple Blood Test, Our Body’s Gut Bacteria Can Help Detect Early-stage Colorectal Cancer

New Findings from Universal DX: Through a Simple Blood Test, Our Body’s Gut Bacteria Can Help Detect Early-stage Colorectal Cancer

Universal DX Presents Data at EACR Virtual Congress; Top-scoring Poster Shows Accurate Detection of Colorectal Advanced Adenomas

Universal DX Presents Data at EACR Virtual Congress; Top-scoring Poster Shows Accurate Detection of Colorectal Advanced Adenomas

Cancer Prevention and Early Detection Is One Step Closer as Universal DX Announces Breakthrough Study Results from Its Multi-omics + Computational Biology + Machine Learning Blood Test

Cancer Prevention and Early Detection Is One Step Closer as Universal DX Announces Breakthrough Study Results from Its Multi-omics + Computational Biology + Machine Learning Blood Test

Universal Diagnostics Initiates Observational Study in the US to Evaluate Cell Free DNA Blood Test for Adenomas and Colorectal Cancer

Universal Diagnostics Initiates Observational Study in the US to Evaluate Cell Free DNA Blood Test for Adenomas and Colorectal Cancer

Universal Diagnostics Presents Promising Data on Lung Cancer Detection using Blood-Based Methylation Test at the IASLC 2020 World Conference on Lung Cancer

Universal Diagnostics Presents Promising Data on Lung Cancer Detection using Blood-Based Methylation Test at the IASLC 2020 World Conference on Lung Cancer

Revolutionizing Colorectal Cancer Screening One Blood Test at a Time

Revolutionizing Colorectal Cancer Screening One Blood Test at a Time

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

Quest Collaborates With Universal DX For Advanced Blood Test Screening For Colorectal Cancer

Quest Collaborates With Universal DX For Advanced Blood Test Screening For Colorectal Cancer

Universal DX Closes $70M Series B Round, Inks Deal With Quest to Provide Colorectal Cancer Test

Universal DX Closes $70M Series B Round, Inks Deal With Quest to Provide Colorectal Cancer Test

Universal DX capta 51 millones en un ronda con el gigante norteamericano Quest

Universal DX capta 51 millones en un ronda con el gigante norteamericano Quest

A New Blood Test to Screen for Colorectal Cancer Shows Promise

A New Blood Test to Screen for Colorectal Cancer Shows Promise

Universal DX Eyeing Approval for Colorectal Cancer Early Detection Test After Positive Data

Universal DX Eyeing Approval for Colorectal Cancer Early Detection Test After Positive Data

MedTech Innovator Unveils Top 50 Medtech Startups Selected for Annual Showcase and Accelerator

MedTech Innovator Unveils Top 50 Medtech Startups Selected for Annual Showcase and Accelerator

New Liquid Biopsy Data at ASCO Highlights Commercial Push Into Early Cancer Detection

New Liquid Biopsy Data at ASCO Highlights Commercial Push Into Early Cancer Detection

New blood-based CRC test is more than 90% accurate, study says

New blood-based CRC test is more than 90% accurate, study says

Spanish Cancer Company Universal DX to Commercialize Methylation Method for Lung Cancer Detection

Spanish Cancer Company Universal DX to Commercialize Methylation Method for Lung Cancer Detection